Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study

Published:2023-07 Issue: Volume:187 Page:174-184
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Normanno Nicola^ORCID,De Luca Antonella^ORCID,Abate Riziero Esposito,Morabito Alessandro,Milella Michele,Tabbò Fabrizio^ORCID,Curigliano Giuseppe^ORCID,Masini Cristina,Marchetti Paolo,Pruneri Giancarlo,Guarneri Valentina^ORCID,Frassineti Giovanni L.,Fasola Gianpiero^ORCID,Adamo Vincenzo^ORCID,Daniele Bruno,Berardi Rossana,Feroce Florinda,Maiello Evaristo^ORCID,Pinto Carmine^ORCID

Funder

Bristol-Myers Squibb Co

Takeda Oncology

Eli Lilly and Co

Daiichi Sankyo Co Ltd

AstraZeneca plc

Novartis AG

Amgen Inc

Roche

Bayer Healthcare

Janssen Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary;Yates;Ann Oncol,2018

2. Delivering precision oncology to patients with cancer;Mateo;Nat Med,2022

3. Precision medicine in oncology II: economics of targeted agents and immuno-oncology drugs;Huntington;J Clin Oncol,2020

4. Cancer biomarkers in the era of precision oncology: addressing the needs of patients and health systems;Normanno;Semin Cancer Biol,2022

5. The emerging clinical relevance of genomics in cancer medicine;Berger;Nat Rev Clin Oncol,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering effective biomarker-driven precision oncology: A call to action;European Journal of Cancer;2024-09

2. Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts;Journal of the Formosan Medical Association;2024-09

3. Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the “MOZART” prospective observational study;The Oncologist;2024-08-23

4. Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study;Frontiers in Oncology;2024-07-09

5. HER2-directed therapy following ctDNA-identified ERBB2 amplification in patients with advanced gastroesophageal cancer: exploration of real-world outcomes;ESMO Gastrointestinal Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3